Mason
LightNews LightNews
banner
mgmuir.bsky.social
Mason
@mgmuir.bsky.social
340 followers 610 following 4 posts
WashU Medical student (MD) - Oncology
Cancer Bioinformatics #MedSky #OncSky #AI #Transcriptomics #Immunotherapy
Via Cornell, NCI | views are my own
Posts Replies Media Videos
Reposted by Mason
fumikochino.bsky.social
"I want to make a difference in the cancer space, and I have a limited amount of time and energy available to do it. Wading through uncurated content, hostile posts, & medical misinformation isn’t how I want to spend my days." #oncSky #canSky 💙 migration #eXodus

www.statnews.com/2024/11/22/t...
Why cancer advocates like me are leaving X
“It’s sad to see the era of Twitter cancer communities end,” writes cancer advocate Janet Freeman-Daily.
www.statnews.com
November 22, 2024 at 3:05 PM
Reposted by Mason
shikhajainmd.bsky.social
Trying my hand at a starter pack. If you know good hematology or oncology people or orgs to follow let me know and I’ll add!

go.bsky.app/4pWmu3W
November 19, 2024 at 2:50 AM
Reposted by Mason
shikhajainmd.bsky.social
Trying my hand at a starter pack.
#OncSky #MedOnc #womeninoncology #HemeOnc #hemeSky
#MedSky

go.bsky.app/4pWmu3W
November 19, 2024 at 3:15 AM
Reposted by Mason
fuqekgs.medsky.social
Please let me know if you are a med student and want to be added #MedSky

go.bsky.app/KjNw3xW
November 11, 2024 at 10:50 PM
Reposted by Mason
viveksubbiah.bsky.social
🚨The exodus of #MedTwitter #OncSky to #BlueSky @bsky.app is fascinating. All the #Twitter birds are now flying freely in the Bluesky. 🐦💙 Will #Bluesky succeed where #Threads and #Mastodon struggled?#MedTwitterMigration #BlueSkySocial @oncoalert.bsky.social @tmprowell.bsky.social
November 19, 2024 at 2:01 AM
mgmuir.bsky.social
Incredible research by WashU Medicine, Siteman Cancer Center, and BJH; Neoantigen cancer vaccines are incredibly promising! #MedSky #OncSky

medicine.washu.edu/news/vaccine...

genomemedicine.biomedcentral.com/articles/10....
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients - Genome Medicine
Background Neoantigen vaccines can induce or enhance highly specific antitumor immune responses with minimal risk of autoimmunity. We have developed a neoantigen DNA vaccine platform capable of effici...
genomemedicine.biomedcentral.com
November 18, 2024 at 6:36 PM